| Childhood obesity: causes, consequences, and management M Gurnani, C Birken, J Hamilton Pediatric Clinics 62 (4), 821-840, 2015 | 531 | 2015 |
| Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer. LL Nielsen, P Lipari, J Dell, M Gurnani, G Hajian Clinical cancer research: an official journal of the American Association …, 1998 | 180 | 1998 |
| Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer M Gurnani, P Lipari, J Dell, B Shi, LL Nielsen Cancer chemotherapy and pharmacology 44, 143-151, 1999 | 166 | 1999 |
| Inactivation of Sterol Δ5,6-Desaturase Attenuates Virulence in Candida albicans AS Chau, M Gurnani, R Hawkinson, M Laverdiere, A Cacciapuoti, ... Antimicrobial agents and chemotherapy 49 (9), 3646-3651, 2005 | 102 | 2005 |
| Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models LL Nielsen, M Gurnani, J Syed, J Dell, B Hartman, M Cartwright, ... Human gene therapy 9 (5), 681-694, 1998 | 99 | 1998 |
| Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors SS Walker, Y Xu, I Triantafyllou, MF Waldman, C Mendrick, N Brown, ... Antimicrobial agents and chemotherapy 55 (11), 5099-5106, 2011 | 89 | 2011 |
| Histopathology of Salivary and Mammary Gland Tumors in Transgenic Mice Expressing a Human Ha-ras Oncogene LL Nielsen, CM Discafani, M Gurnani, RD Tyler Cancer research 51 (14), 3762-3767, 1991 | 70 | 1991 |
| Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories LK Najvar, A Cacciapuoti, S Hernandez, J Halpern, R Bocanegra, ... Antimicrobial agents and chemotherapy 48 (3), 758-764, 2004 | 66 | 2004 |
| Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer models LL Nielsen, B Shi, G Hajian, B Yaremko, P Lipari, E Ferrari, M Gurnani, ... Cancer research 59 (23), 5896-5901, 1999 | 59 | 1999 |
| The use of laser scanning cytometry to assess depth of penetration of adenovirus p53 gene therapy in human xenograft biopsies MJ Grace, L Xie, ML Musco, S Cui, M Gurnani, R DiGiacomo, A Chang, ... The American journal of pathology 155 (6), 1869-1878, 1999 | 50 | 1999 |
| In wap-ras transgenic mice, tumor phenotype but not cyclophosphamide-sensitivity is affected by genetic background. LL Nielsen, M Gurnani, JJ Catino, RD Tyler Anticancer research 15 (2), 385-392, 1995 | 19 | 1995 |
| Enhanced efficacy of the farnesyl protein transferase inhibitor SCH66336 in combination with paclitaxel B Shi, M Gurnani, B Yaremko, S Lee, J Chen, P Lipari, E Ferrari, ... Proc Am Assoc Cancer Res 40, 524, 1999 | 17 | 1999 |
| Development of a nude mouse model of ras-mediated neoplasia using WR21 cells from a transgenic mouse salivary tumor. LL Nielsen, M Gurnani, G Porter, S Trexler, D Emerson, RD Tyler In Vivo (Athens, Greece) 8 (3), 295-302, 1994 | 6 | 1994 |
| Adenovirus-mediated p53 gene therapy synergizes with paclitaxel against human ovarian, mammary, prostate, head and neck, and liver cancer LL Nielsen, P Lipari, J Dell, M Gurnani, E Maxwell, G Hajian, GW Demers CANCER GENE THERAPY 4 (6), O4-O4, 1997 | 2 | 1997 |
| COMPARISdN OF two METH0D6 (EfA AND RK Patel, M Gurnani | | |
